SOURCE: Linkwell Corporation

October 18, 2005 10:26 ET

Linkwell Corporation Today Releases a Report on Their Company Prepared by Analyst Jeff Helleberg on October 11th, 2005

FT LAUDERDALE, FL -- (MARKET WIRE) -- October 18, 2005 -- LWLL - Linkwell Corporation (OTC BB: LWLL) today released a report on their company prepared by analyst Jeff Helleberg on October 11th, 2005. The complete, unedited text of that report is as follows.

Stock Symbol-                LWLL.OB
Shares-                   45,304,139
Float-                     4,300,000
Recent price-                  $0.30
Short term price-              $1.35
Web Site - 
Phone-                1-561-487-3674
NEWS FLASH: Linkwell has a low valuation all but eliminating the uncertainty for growth including, lower, more achievable forward estimates which is a strong catalyst for investors considering buying this stock. We remain very comfortable with our earnings forecast and view LWLL as having among the best relative earnings visibility in our coverage group. The estimated EPS for 2005 is above expectations, and we look for rising earnings potential to continue to move the stock toward our target.


Investment Highlights

--  EPA studies reveal since the 1980's up to 20% of the thousands of
    disinfectants on the market do not effectively kill disease-causing
--  The products sold by Linkwell have proven to be 100% effective
--  The Company manufactures its products at two large  factories located
    in Shanghai
--  The Company currently has over 5000 customers

Linkwell Corporation is headquartered in the United States but does almost all of its business in China. Operating out of Shanghai, Linkwell is a leading developer, manufacturer, and marketer of disinfectant health care products through its 90% owned subsidiary Shanghai Likang Disinfectant High-Tech Company (Likang). Likang has been a viable company since 1988 but was formally established in 1993. Linkwell offers a variety of products including various skin and mucous membrane disinfectants, medical device and equipment disinfectants, surface and environment disinfectants, and hand disinfectants. Its brands are industry leaders in China and are the only domestic ones with a national presence. LWLL regards hospital and medical facility disinfecting products as its primary business focus. Recently, a series of global infection crises have captured public attention and thus the increased demand for their products.

Linkwell is an emerging growth company with innovative products. This is a ground floor opportunity for investors as the company has recently gone public on the US stock exchange. Global epidemics are a part of life as a deadly strain of bird flu continues to spread in Asia at present. Three times this past century, bird influenzas have spread to people, causing millions of deaths. Infection crises have captured public attention, which leads to a sharp demand for disinfectant products.


LWLL is poised to advance as revenues and earnings benefit from the Company's many products and the increasing demand for them. We believe an excellent management team, solid product planning and tremendous execution enable Linkwell to take a distinct advantage over most of their domestic rivals which typically have at most a handful of products in their stables. Linkwell has pioneered what we believe is a unique business model focused on its large product line and entry into the nascent market for mass retail non-medical, daily-use disinfectant products in China. Their strategy has succeeded in the market segments in which the company competes and should only get stronger.

Approximately 30% of Likang's end sales are achieved by the company's internal sales force, while 70% are achieved by independent salespersons, dealers and agents. We believe LWLL's discounted valuation combined with renewed financial flexibility and improving fundamentals provide a compelling investment opportunity. We have set a short-term price target on the common shares at $1.35. If our target is achieved, this would result in a return of over 400%. We therefore believe Linkwell is highly undervalued and gains like this are possible if the company adheres to its business plan, and conditions in this sector and the economy remain positive. Over the next three years, Linkwell seeks to raise additional capital from new investors to fund organic growth as well as acquisitions.

Linkwell is committed to launching new innovative products into a market which is also poised to see exponential growth due to the increasing concern with healthcare and sanitary effectiveness in a country that is seeing rising living standards

About Linkwell Corporation

Linkwell Corporation is a leading developer, manufacturer, and marketer of disinfectant healthcare products in the People's Republic of China through its 90% owned subsidiary Shanghai Likang Disinfectant High Tech Comapany (Likang). Linkwell Corporation is a U.S. corporation headquartered in Boca Raton, Florida and is publicly traded on the OTC Bulletin Board Exchange under the symbol (OTCBB: LWLL).

Linkwell's disinfectant healthcare products are the leading and only nationally recognized domestic Chinese brand in this market segment. Linkwell products include disinfectant, liquid and tablet products, as well as disinfectant instruments, devices, materials. These may also include air disinfecting machines, hot press bags, disinfection swabs, and disinfection tampons. Through Likang, Linkwell is the only domestic Chinese company that has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of the People's Republic of China. All inventory and order fulfillment is carried out of a 21,500 square foot facility in Shanghai's Jiading district. The company's products have gradually made their way from medical disinfection to also include civil disinfection, industrial disinfection, and agricultural and livestock disinfection.. For more info about the company, please visit

Safe Harbor Statement

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets.

Contact Information